MarketAnalysisMarketAnalysis
NYSE:ABBV

AbbVie Inc. - NYSE:ABBV - Comprehensive analysis

Free evaluation through quantitative algorithms AbbVie Inc. - NYSE:ABBV

Quant Rating

1

Strong Sell

2

Sell

3

Hold

4

Buy

5

Strong Buy


The overall quant rating is not an average of the factor grades listed.Instead, it gives greater weight to the metrics with the strongest predictive value.

Growth-Scoring Model Detail

Name

Fatcor
Percentage

Total Revenue Growth Over Prior Year

3.71

Market

46

Sector

52

Gross Profit Growth Over Prior Year

5.37

Market

47

Sector

55

EBITDA Growth Over Prior Year

-0.57

Market

23

Sector

27

EBITA Growth Over Prior Year

-0.63

Market

26

Sector

32

EBIT Growth Over Prior Year

0.92

Market

31

Sector

34

Earnings from Cont. Ops. Growth Over Prior Year

-12.05

Market

23

Sector

31

Net Income Growth Over Prior Year

-12.03

Market

25

Sector

32

Normalized Net Income Growth Over Prior Year

-0.65

Market

34

Sector

27

Diluted EPS before Extra Growth Over Prior Year

-12.13

Market

24

Sector

31

A/R Growth Over Prior Year

-2.12

Market

29

Sector

22

Inventory Growth Over Prior Year

2

Market

71

Sector

76

PPE Net Growth Over Prior Year

2.16

Market

49

Sector

67

Total Assets Growth Over Prior Year

0.33

Market

37

Sector

51

Tangible Book Value Growth Over Prior Year

0

Market

0

Sector

0

Common Equity Growth Over Prior Year

-67.91

Market

1

Sector

6

Cash from Ops. Growth Over Prior Year

-17.66

Market

17

Sector

21

CAPEX Growth Over Prior Year

25.4

Market

83

Sector

78

Dividend per Share Growth Over Prior Year

5.01

Market

55

Sector

97

Levered Free Cash Flow Growth Over Prior Year

-13.12

Market

26

Sector

28

Unlevered Free Cash Flow Growth Over Prior Year

-10.84

Market

27

Sector

27

Profitability-Scoring Model Detail

Name

Fatcor
Percentage

Gross Margin %

71

Market

86

Sector

73

SG&A Margin %

23.9

Market

73

Sector

37

EBITDA Margin %

46.5

Market

86

Sector

99

EBITA Margin %

45.2

Market

95

Sector

99

EBIT Margin %

31.6

Market

85

Sector

97

Earnings from Cont. Ops Margin %

7.61

Market

26

Sector

82

Net Income Margin %

7.59

Market

27

Sector

82

Net Income Avail. for Common Margin %

7.52

Market

27

Sector

82

Normalized Net Income Margin %

17.64

Market

82

Sector

95

Levered Free Cash Flow Margin %

34.9

Market

93

Sector

98

Unlevered Free Cash Flow Margin %

38

Market

93

Sector

98

Return on Assets %

8.25

Market

74

Sector

93

Return on Capital %

15.68

Market

84

Sector

96

Return on Equity %

63

Market

93

Sector

99

Return on Common Equity %

62

Market

92

Sector

99

Total Asset Turnover

0.42

Market

40

Sector

57

Sub-Scoring Model

Valuation
Momentum
Growth
Profitability
80
60
40
20
Valuation: 35
Momentum: 53
Growth: 36
Profitability: 72

Valuation-Scoring Model Detail

Name

Fatcor
Percentage

TEV/LTM Total Revenue

6.57

Market

78

Sector

71

TEV/LTM EBITDA

13.68

Market

52

Sector

76

P/LTM Normalized EPS

31.9

Market

56

Sector

59

P/BV

95

Market

100

Sector

100

TEV/LTM Unlevered FCF

17.04

Market

26

Sector

65

Momentum-Scoring Model Detail

Name

Fatcor
Percentage

1M Price Performance

-15.43

Market

9

Sector

44

3M Price Performance

2.29

Market

71

Sector

84

6M Price Performance

-6.23

Market

53

Sector

71

9M Price Performance

7.02

Market

68

Sector

81

1Y Price Performance

8.78

Market

62

Sector

83

Start analyzing AbbVie Inc. - NYSE:ABBV with easy-to-understand research reports

Start analyzing Recent popular companies with easy-to-understand research reports